TickerFactsScreenerDevelopers

Inmune Bio, Inc. (INMB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$761.8K2018: -$2.06M2019: -$5.38M2020: -$8.94M2021: -$28.50M2022: -$22.69M2023: -$11.98M2024: -$33.36M2025: -$22.58M-$22.58M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$22.58M+32.3%
2024-$33.36M-178.5%
2023-$11.98M+47.2%
2022-$22.69M+20.4%
2021-$28.50M-218.7%
2020-$8.94M-66.1%
2019-$5.38M-161.5%
2018-$2.06M-170.3%
2017-$761.8K—